Found: 66
Select item for more details and to access through your institution.
Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 431, doi. 10.1002/ajh.26474
- By:
- Publication type:
- Article
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40328-4
- By:
- Publication type:
- Article
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0211286
- By:
- Publication type:
- Article
Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 7, p. 1013, doi. 10.1093/cid/cix916
- By:
- Publication type:
- Article
Direct, indirect and total effect of HIV coinfection on the risk of non‐liver‐related cancer in hepatitis C virus‐infected patients treated by direct‐acting antivirals: a mediation analysis.
- Published in:
- HIV Medicine, 2021, v. 22, n. 10, p. 924, doi. 10.1111/hiv.13153
- By:
- Publication type:
- Article
Induction of cyclooxygenase-2 by tumor promoters in transformed and cytochrome P450 2E1-expressing hepatocytes.
- Published in:
- Carcinogenesis, 2002, v. 23, n. 1, p. 73, doi. 10.1093/carcin/23.1.73
- By:
- Publication type:
- Article
2D-shear wave elastography: number of acquisitions can be reduced according to clinical setting.
- Published in:
- Insights into Imaging, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13244-021-01090-7
- By:
- Publication type:
- Article
Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07076-0
- By:
- Publication type:
- Article
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07076-0
- By:
- Publication type:
- Article
Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1872, doi. 10.1111/liv.15914
- By:
- Publication type:
- Article
The NAFLD burden on mortality and morbidities in general population: A community‐based longitudinal study (NASH‐CO study).
- Published in:
- Liver International, 2023, v. 43, n. 10, p. 2096, doi. 10.1111/liv.15674
- By:
- Publication type:
- Article
ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
- Published in:
- Liver International, 2022, v. 42, n. 6, p. 1386, doi. 10.1111/liv.15159
- By:
- Publication type:
- Article
The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population‐based follow‐up study (NASHCO).
- Published in:
- Liver International, 2022, v. 42, n. 3, p. 595, doi. 10.1111/liv.15171
- By:
- Publication type:
- Article
Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol use.
- Published in:
- Liver International, 2022, v. 42, n. 2, p. 350, doi. 10.1111/liv.15081
- By:
- Publication type:
- Article
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis.
- Published in:
- Liver International, 2018, v. 38, n. 9, p. 1583, doi. 10.1111/liv.13727
- By:
- Publication type:
- Article
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1314, doi. 10.1111/liv.13383
- By:
- Publication type:
- Article
205: LIVER STIFFNESS: A NEW, RAPID AND NON-INVASIVE METHOD OF CENTRAL VENOUS PRESSURE EVALUATION IN PATIENTS WITH CONGENITAL HEART DISEASE.
- Published in:
- Cardiovascular Journal of Africa, 2013, v. 24, n. 1, p. 147
- By:
- Publication type:
- Article
Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1728, doi. 10.1001/jama.2015.3860
- By:
- Publication type:
- Article
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 11, p. 1555, doi. 10.1007/s00228-019-02725-x
- By:
- Publication type:
- Article
Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
- Published in:
- Clinical & Translational Gastroenterology, 2019, v. 10, n. 4, p. e00023, doi. 10.14309/ctg.0000000000000023
- By:
- Publication type:
- Article
Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real‐world cohorts.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 12, p. 1050, doi. 10.1111/jvh.13738
- By:
- Publication type:
- Article
Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 11, p. 1635, doi. 10.1111/jvh.13600
- By:
- Publication type:
- Article
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 920, doi. 10.1111/apt.17699
- By:
- Publication type:
- Article
Liver‐related and extrahepatic events in patients with non‐alcoholic fatty liver disease: a retrospective competing risks analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 5, p. 604, doi. 10.1111/apt.16763
- By:
- Publication type:
- Article
Long‐term prognosis of patients with metabolic (dysfunction)‐associated fatty liver disease by non‐invasive methods.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 5, p. 580, doi. 10.1111/apt.16760
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2012, v. 107, n. 12, p. 1862, doi. 10.1038/ajg.2012.331
- By:
- Publication type:
- Article
A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 7, p. 1255, doi. 10.1038/ajg.2011.100
- By:
- Publication type:
- Article
Prognostic Indices for Budd–Chiari Syndrome: Valid for Clinical Studies but Insufficient for Individual Management.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2009, v. 104, n. 5, p. 1140, doi. 10.1038/ajg.2009.63
- By:
- Publication type:
- Article
Validation and Comparison of Simple Noninvasive Indexes for Predicting Liver Fibrosis in HIV-HCV-Coinfected Patients: ANRS CO3 Aquitaine Cohort.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2008, v. 103, n. 8, p. 1973, doi. 10.1111/j.1572-0241.2008.01954.x
- By:
- Publication type:
- Article
TT Virus Infection During Chronic Hepatitis C.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2000, v. 95, n. 7, p. 1765, doi. 10.1111/j.1572-0241.2000.02138.x
- By:
- Publication type:
- Article
Hypervascular nodule in a fibrotic liver overloaded with iron: identification of a premalignant area with preserved liver architecture.
- Published in:
- Comparative Hepatology, 2005, v. 4, p. 5, doi. 10.1186/1476-5926-4-5
- By:
- Publication type:
- Article
Effects of Helicobacter pylori Infection on Gut Appetite Peptide (Leptin, Ghrelin) Expression in Elderly Inpatients.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2006, v. 61, n. 11, p. 1144, doi. 10.1093/gerona/61.11.1144
- By:
- Publication type:
- Article
Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047715
- By:
- Publication type:
- Article
HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients.
- Published in:
- BMC Infectious Diseases, 2014, v. 14, n. 1, p. 405, doi. 10.1186/1471-2334-14-405
- By:
- Publication type:
- Article
Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 4, p. 848, doi. 10.1111/jgh.13219
- By:
- Publication type:
- Article
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 15, p. 1287, doi. 10.1001/jama.2024.1447
- By:
- Publication type:
- Article
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD.
- Published in:
- International Journal of Endocrinology, 2013, p. 1, doi. 10.1155/2013/428542
- By:
- Publication type:
- Article
Actualités sur le virus de l'hépatite Delta.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, p. 5, doi. 10.1684/hpg.2022.2366
- By:
- Publication type:
- Article
Les points-clés à retenir/avis d'experts : du dépistage au traitement de l'hépatite chronique à virus Delta.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, p. 45, doi. 10.1684/hpg.2022.2349
- By:
- Publication type:
- Article
Le FibroScan™ a 20 ans, l'âge de la maturité ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 6, p. 563, doi. 10.1684/hpg.2020.1991
- By:
- Publication type:
- Article
Meta-analyses of FibroTest diagnostic value in chronic liver disease.
- Published in:
- BMC Gastroenterology, 2007, v. 7, p. 40, doi. 10.1186/1471-230X-7-40
- By:
- Publication type:
- Article
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.
- Published in:
- BMC Gastroenterology, 2006, v. 6, p. 34, doi. 10.1186/1471-230X-6-34
- By:
- Publication type:
- Article
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
- Published in:
- BMC Gastroenterology, 2006, v. 6, p. 6, doi. 10.1186/1471-230X-6-6
- By:
- Publication type:
- Article
Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.
- Published in:
- Annals of Gastroenterology, 2017, v. 30, n. 3, p. 327, doi. 10.20524/aog.2017.0136
- By:
- Publication type:
- Article